ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) saw a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 16,382 shares, a decrease of 47.3% from the July 15th total of 31,101 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 53,359 shares, the short-interest ratio is currently 0.3 days.
ALPS Group Inc Ordinary Share Trading Down 2.4%
ALPS stock opened at $0.32 on Friday. The company has a market capitalization of $53.25 million, a price-to-earnings ratio of 0.97 and a beta of -0.10. The firm has a 50 day simple moving average of $0.54. ALPS Group Inc Ordinary Share has a 12-month low of $0.29 and a 12-month high of $15.00.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a report on Monday, July 6th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.
About ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See Also
- Five stocks we like better than ALPS Group Inc Ordinary Share
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
